Benitec Biopharma Statistics
Total Valuation
BNTC has a market cap or net worth of $431.30 million. The enterprise value is $333.35 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BNTC has 26.25 million shares outstanding. The number of shares has increased by 97.17% in one year.
| Current Share Class | 26.25M |
| Shares Outstanding | 26.25M |
| Shares Change (YoY) | +97.17% |
| Shares Change (QoQ) | +6.63% |
| Owned by Insiders (%) | 3.67% |
| Owned by Institutions (%) | 45.63% |
| Float | 13.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.36 |
| P/TBV Ratio | 4.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 54.67, with a Debt / Equity ratio of 0.01.
| Current Ratio | 54.67 |
| Quick Ratio | 54.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.46% and return on invested capital (ROIC) is -35.84%.
| Return on Equity (ROE) | -52.46% |
| Return on Assets (ROA) | -34.39% |
| Return on Invested Capital (ROIC) | -35.84% |
| Return on Capital Employed (ROCE) | -42.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.00M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.76% in the last 52 weeks. The beta is 0.41, so BNTC's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +45.76% |
| 50-Day Moving Average | 14.21 |
| 200-Day Moving Average | 13.24 |
| Relative Strength Index (RSI) | 56.39 |
| Average Volume (20 Days) | 62,712 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -41.77M |
| Pretax Income | -37.92M |
| Net Income | -37.92M |
| EBITDA | -41.70M |
| EBIT | -41.77M |
| Earnings Per Share (EPS) | -$1.05 |
Full Income Statement Balance Sheet
The company has $97.74 million in cash and $849,000 in debt, giving a net cash position of $96.90 million or $3.69 per share.
| Cash & Cash Equivalents | 97.74M |
| Total Debt | 849,000 |
| Net Cash | 96.90M |
| Net Cash Per Share | $3.69 |
| Equity (Book Value) | 97.30M |
| Book Value Per Share | 3.71 |
| Working Capital | 96.72M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$23.59 million and capital expenditures -$18,000, giving a free cash flow of -$23.61 million.
| Operating Cash Flow | -23.59M |
| Capital Expenditures | -18,000 |
| Free Cash Flow | -23.61M |
| FCF Per Share | -$0.90 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BNTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -97.17% |
| Shareholder Yield | -97.17% |
| Earnings Yield | -8.81% |
| FCF Yield | -5.49% |
Dividend Details Analyst Forecast
The average price target for BNTC is $24.80, which is 50.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.80 |
| Price Target Difference | 50.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 26, 2023. It was a reverse split with a ratio of 1:17.
| Last Split Date | Jul 26, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:17 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |